Blood Plasma Derivatives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

The global market for Blood Plasma Derivatives was estimated to be worth US$ 30890 million in 2023 and is forecast to a readjusted size of US$ 47030 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030

Blood Plasma Derivatives Market Size

M= millions and B=billions

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Derivatives, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Plasma Derivatives by region & country, by Type, and by Application.

The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Derivatives.

Market Segmentation

• Report Metric

• Details

• Report Title

• Blood Plasma Derivatives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 47030 million

• CAGR(2024-2030)

• 5.7%

• Market Size Available for Years

• 2019-2030

• Global Blood Plasma Derivatives Companies Covered

• Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG, CSL Limited, Takeda, China Biologic Products, Kedrion Biopharma, BDI Pharma, Bayer AG, Hualan Biological Engineering

• Global Blood Plasma Derivatives Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Blood Plasma Derivatives Market, Segment by Type

• Albumin

  Factor VIII

  Factor IX

  Immunoglobulin

  Hyperimmune Globulin

  Others

• Global Blood Plasma Derivatives Market, Segment by Application

• Hospitals

  Clinics

  Other End Users

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Plasma Derivatives manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blood Plasma Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blood Plasma Derivatives in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Blood Plasma Derivatives Product Introduction
    1.2 Global Blood Plasma Derivatives Market Size Forecast
    1.3 Blood Plasma Derivatives Market Trends & Drivers
        1.3.1 Blood Plasma Derivatives Industry Trends
        1.3.2 Blood Plasma Derivatives Market Drivers & Opportunity
        1.3.3 Blood Plasma Derivatives Market Challenges
        1.3.4 Blood Plasma Derivatives Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Blood Plasma Derivatives Players Revenue Ranking (2023)
    2.2 Global Blood Plasma Derivatives Revenue by Company (2019-2024)
    2.3 Key Companies Blood Plasma Derivatives Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Blood Plasma Derivatives Product Offered
    2.5 Key Companies Time to Begin Mass Production of Blood Plasma Derivatives
    2.6 Blood Plasma Derivatives Market Competitive Analysis
        2.6.1 Blood Plasma Derivatives Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Blood Plasma Derivatives Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Albumin
        3.1.2 Factor VIII
        3.1.3 Factor IX
        3.1.4 Immunoglobulin
        3.1.5 Hyperimmune Globulin
        3.1.6 Others
    3.2 Global Blood Plasma Derivatives Sales Value by Type
        3.2.1 Global Blood Plasma Derivatives Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Blood Plasma Derivatives Sales Value, by Type (2019-2030)
        3.2.3 Global Blood Plasma Derivatives Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Other End Users
    4.2 Global Blood Plasma Derivatives Sales Value by Application
        4.2.1 Global Blood Plasma Derivatives Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Blood Plasma Derivatives Sales Value, by Application (2019-2030)
        4.2.3 Global Blood Plasma Derivatives Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Blood Plasma Derivatives Sales Value by Region
        5.1.1 Global Blood Plasma Derivatives Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Blood Plasma Derivatives Sales Value by Region (2019-2024)
        5.1.3 Global Blood Plasma Derivatives Sales Value by Region (2025-2030)
        5.1.4 Global Blood Plasma Derivatives Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Blood Plasma Derivatives Sales Value, 2019-2030
        5.2.2 North America Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Blood Plasma Derivatives Sales Value, 2019-2030
        5.3.2 Europe Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Blood Plasma Derivatives Sales Value, 2019-2030
        5.4.2 Asia Pacific Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Blood Plasma Derivatives Sales Value, 2019-2030
        5.5.2 South America Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Blood Plasma Derivatives Sales Value, 2019-2030
        5.6.2 Middle East & Africa Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Blood Plasma Derivatives Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Blood Plasma Derivatives Sales Value
    6.3 United States
        6.3.1 United States Blood Plasma Derivatives Sales Value, 2019-2030
        6.3.2 United States Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Blood Plasma Derivatives Sales Value, 2019-2030
        6.4.2 Europe Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Blood Plasma Derivatives Sales Value, 2019-2030
        6.5.2 China Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Blood Plasma Derivatives Sales Value, 2019-2030
        6.6.2 Japan Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Blood Plasma Derivatives Sales Value, 2019-2030
        6.7.2 South Korea Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Blood Plasma Derivatives Sales Value, 2019-2030
        6.8.2 Southeast Asia Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Blood Plasma Derivatives Sales Value, 2019-2030
        6.9.2 India Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Grifols
        7.1.1 Grifols Profile
        7.1.2 Grifols Main Business
        7.1.3 Grifols Blood Plasma Derivatives Products, Services and Solutions
        7.1.4 Grifols Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.1.5 Grifols Recent Developments
    7.2 SK Plasma
        7.2.1 SK Plasma Profile
        7.2.2 SK Plasma Main Business
        7.2.3 SK Plasma Blood Plasma Derivatives Products, Services and Solutions
        7.2.4 SK Plasma Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.2.5 SK Plasma Recent Developments
    7.3 Fusion Health Care
        7.3.1 Fusion Health Care Profile
        7.3.2 Fusion Health Care Main Business
        7.3.3 Fusion Health Care Blood Plasma Derivatives Products, Services and Solutions
        7.3.4 Fusion Health Care Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.3.5 Biotest AG Recent Developments
    7.4 Biotest AG
        7.4.1 Biotest AG Profile
        7.4.2 Biotest AG Main Business
        7.4.3 Biotest AG Blood Plasma Derivatives Products, Services and Solutions
        7.4.4 Biotest AG Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.4.5 Biotest AG Recent Developments
    7.5 Green Cross Corporation
        7.5.1 Green Cross Corporation Profile
        7.5.2 Green Cross Corporation Main Business
        7.5.3 Green Cross Corporation Blood Plasma Derivatives Products, Services and Solutions
        7.5.4 Green Cross Corporation Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.5.5 Green Cross Corporation Recent Developments
    7.6 Baxter International
        7.6.1 Baxter International Profile
        7.6.2 Baxter International Main Business
        7.6.3 Baxter International Blood Plasma Derivatives Products, Services and Solutions
        7.6.4 Baxter International Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.6.5 Baxter International Recent Developments
    7.7 LFB
        7.7.1 LFB Profile
        7.7.2 LFB Main Business
        7.7.3 LFB Blood Plasma Derivatives Products, Services and Solutions
        7.7.4 LFB Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.7.5 LFB Recent Developments
    7.8 Octapharma AG
        7.8.1 Octapharma AG Profile
        7.8.2 Octapharma AG Main Business
        7.8.3 Octapharma AG Blood Plasma Derivatives Products, Services and Solutions
        7.8.4 Octapharma AG Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.8.5 Octapharma AG Recent Developments
    7.9 CSL Limited
        7.9.1 CSL Limited Profile
        7.9.2 CSL Limited Main Business
        7.9.3 CSL Limited Blood Plasma Derivatives Products, Services and Solutions
        7.9.4 CSL Limited Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.9.5 CSL Limited Recent Developments
    7.10 Takeda
        7.10.1 Takeda Profile
        7.10.2 Takeda Main Business
        7.10.3 Takeda Blood Plasma Derivatives Products, Services and Solutions
        7.10.4 Takeda Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.10.5 Takeda Recent Developments
    7.11 China Biologic Products
        7.11.1 China Biologic Products Profile
        7.11.2 China Biologic Products Main Business
        7.11.3 China Biologic Products Blood Plasma Derivatives Products, Services and Solutions
        7.11.4 China Biologic Products Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.11.5 China Biologic Products Recent Developments
    7.12 Kedrion Biopharma
        7.12.1 Kedrion Biopharma Profile
        7.12.2 Kedrion Biopharma Main Business
        7.12.3 Kedrion Biopharma Blood Plasma Derivatives Products, Services and Solutions
        7.12.4 Kedrion Biopharma Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.12.5 Kedrion Biopharma Recent Developments
    7.13 BDI Pharma
        7.13.1 BDI Pharma Profile
        7.13.2 BDI Pharma Main Business
        7.13.3 BDI Pharma Blood Plasma Derivatives Products, Services and Solutions
        7.13.4 BDI Pharma Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.13.5 BDI Pharma Recent Developments
    7.14 Bayer AG
        7.14.1 Bayer AG Profile
        7.14.2 Bayer AG Main Business
        7.14.3 Bayer AG Blood Plasma Derivatives Products, Services and Solutions
        7.14.4 Bayer AG Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.14.5 Bayer AG Recent Developments
    7.15 Hualan Biological Engineering
        7.15.1 Hualan Biological Engineering Profile
        7.15.2 Hualan Biological Engineering Main Business
        7.15.3 Hualan Biological Engineering Blood Plasma Derivatives Products, Services and Solutions
        7.15.4 Hualan Biological Engineering Blood Plasma Derivatives Revenue (US$ Million) & (2019-2024)
        7.15.5 Hualan Biological Engineering Recent Developments

 8 Industry Chain Analysis
    8.1 Blood Plasma Derivatives Industrial Chain
    8.2 Blood Plasma Derivatives Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Blood Plasma Derivatives Sales Model
        8.5.2 Sales Channel
        8.5.3 Blood Plasma Derivatives Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Blood Plasma Derivatives Market Trends
    Table 2. Blood Plasma Derivatives Market Drivers & Opportunity
    Table 3. Blood Plasma Derivatives Market Challenges
    Table 4. Blood Plasma Derivatives Market Restraints
    Table 5. Global Blood Plasma Derivatives Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Blood Plasma Derivatives Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Blood Plasma Derivatives Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Blood Plasma Derivatives Product Type
    Table 9. Key Companies Time to Begin Mass Production of Blood Plasma Derivatives
    Table 10. Global Blood Plasma Derivatives Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Blood Plasma Derivatives Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Blood Plasma Derivatives Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Blood Plasma Derivatives Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Blood Plasma Derivatives Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Blood Plasma Derivatives Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Blood Plasma Derivatives Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Blood Plasma Derivatives Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Blood Plasma Derivatives Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Blood Plasma Derivatives Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Blood Plasma Derivatives Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Blood Plasma Derivatives Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Blood Plasma Derivatives Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Blood Plasma Derivatives Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Blood Plasma Derivatives Sales Value by Region (2019-2024) & (%)
    Table 27. Global Blood Plasma Derivatives Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Blood Plasma Derivatives Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Blood Plasma Derivatives Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Blood Plasma Derivatives Sales Value, (2025-2030) & (US$ Million)
    Table 31. Grifols Basic Information List
    Table 32. Grifols Description and Business Overview
    Table 33. Grifols Blood Plasma Derivatives Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Blood Plasma Derivatives Business of Grifols (2019-2024)
    Table 35. Grifols Recent Developments
    Table 36. SK Plasma Basic Information List
    Table 37. SK Plasma Description and Business Overview
    Table 38. SK Plasma Blood Plasma Derivatives Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Blood Plasma Derivatives Business of SK Plasma (2019-2024)
    Table 40. SK Plasma Recent Developments
    Table 41. Fusion Health Care Basic Information List
    Table 42. Fusion Health Care Description and Business Overview
    Table 43. Fusion Health Care Blood Plasma Derivatives Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Blood Plasma Derivatives Business of Fusion Health Care (2019-2024)
    Table 45. Fusion Health Care Recent Developments
    Table 46. Biotest AG Basic Information List
    Table 47. Biotest AG Description and Business Overview
    Table 48. Biotest AG Blood Plasma Derivatives Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Blood Plasma Derivatives Business of Biotest AG (2019-2024)
    Table 50. Biotest AG Recent Developments
    Table 51. Green Cross Corporation Basic Information List
    Table 52. Green Cross Corporation Description and Business Overview
    Table 53. Green Cross Corporation Blood Plasma Derivatives Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Blood Plasma Derivatives Business of Green Cross Corporation (2019-2024)
    Table 55. Green Cross Corporation Recent Developments
    Table 56. Baxter International Basic Information List
    Table 57. Baxter International Description and Business Overview
    Table 58. Baxter International Blood Plasma Derivatives Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Blood Plasma Derivatives Business of Baxter International (2019-2024)
    Table 60. Baxter International Recent Developments
    Table 61. LFB Basic Information List
    Table 62. LFB Description and Business Overview
    Table 63. LFB Blood Plasma Derivatives Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Blood Plasma Derivatives Business of LFB (2019-2024)
    Table 65. LFB Recent Developments
    Table 66. Octapharma AG Basic Information List
    Table 67. Octapharma AG Description and Business Overview
    Table 68. Octapharma AG Blood Plasma Derivatives Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Blood Plasma Derivatives Business of Octapharma AG (2019-2024)
    Table 70. Octapharma AG Recent Developments
    Table 71. CSL Limited Basic Information List
    Table 72. CSL Limited Description and Business Overview
    Table 73. CSL Limited Blood Plasma Derivatives Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Blood Plasma Derivatives Business of CSL Limited (2019-2024)
    Table 75. CSL Limited Recent Developments
    Table 76. Takeda Basic Information List
    Table 77. Takeda Description and Business Overview
    Table 78. Takeda Blood Plasma Derivatives Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Blood Plasma Derivatives Business of Takeda (2019-2024)
    Table 80. Takeda Recent Developments
    Table 81. China Biologic Products Basic Information List
    Table 82. China Biologic Products Description and Business Overview
    Table 83. China Biologic Products Blood Plasma Derivatives Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Blood Plasma Derivatives Business of China Biologic Products (2019-2024)
    Table 85. China Biologic Products Recent Developments
    Table 86. Kedrion Biopharma Basic Information List
    Table 87. Kedrion Biopharma Description and Business Overview
    Table 88. Kedrion Biopharma Blood Plasma Derivatives Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Blood Plasma Derivatives Business of Kedrion Biopharma (2019-2024)
    Table 90. Kedrion Biopharma Recent Developments
    Table 91. BDI Pharma Basic Information List
    Table 92. BDI Pharma Description and Business Overview
    Table 93. BDI Pharma Blood Plasma Derivatives Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Blood Plasma Derivatives Business of BDI Pharma (2019-2024)
    Table 95. BDI Pharma Recent Developments
    Table 96. Bayer AG Basic Information List
    Table 97. Bayer AG Description and Business Overview
    Table 98. Bayer AG Blood Plasma Derivatives Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Blood Plasma Derivatives Business of Bayer AG (2019-2024)
    Table 100. Bayer AG Recent Developments
    Table 101. Hualan Biological Engineering Basic Information List
    Table 102. Hualan Biological Engineering Description and Business Overview
    Table 103. Hualan Biological Engineering Blood Plasma Derivatives Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Blood Plasma Derivatives Business of Hualan Biological Engineering (2019-2024)
    Table 105. Hualan Biological Engineering Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Blood Plasma Derivatives Downstream Customers
    Table 109. Blood Plasma Derivatives Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Blood Plasma Derivatives Product Picture
    Figure 2. Global Blood Plasma Derivatives Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 4. Blood Plasma Derivatives Report Years Considered
    Figure 5. Global Blood Plasma Derivatives Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Plasma Derivatives Revenue in 2023
    Figure 7. Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Albumin Picture
    Figure 9. Factor VIII Picture
    Figure 10. Factor IX Picture
    Figure 11. Immunoglobulin Picture
    Figure 12. Hyperimmune Globulin Picture
    Figure 13. Others Picture
    Figure 14. Global Blood Plasma Derivatives Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Blood Plasma Derivatives Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Other End Users
    Figure 19. Global Blood Plasma Derivatives Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Blood Plasma Derivatives Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Blood Plasma Derivatives Sales Value (%), (2019-2030)
    Figure 32. United States Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 53. Blood Plasma Derivatives Industrial Chain
    Figure 54. Blood Plasma Derivatives Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

The global market for Blood Plasma Derivatives was estimated to be worth US$ 30890 million in 2023 and is forecast to a readjusted size of US$ 47030 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Derivatives, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Plasma Derivatives by region & country, by Type, and by Application.

The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Derivatives.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Plasma Derivatives manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blood Plasma Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blood Plasma Derivatives in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.